Applied Optoelectronics, Inc.
AAOI Nasdaq Semiconductors & Related Devices Financials FY2016βFY2025
What Applied Optoelectronics, Inc. does
No business description yet.
- Legal name
- APPLIED OPTOELECTRONICS, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001437749-26-005875
0001158114
Revenue and margins
Applied Optoelectronics, Inc. had $456M of revenue in fiscal 2025, up 82.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$354M in fiscal 2025, β77.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Applied Optoelectronics, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 44.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Applied Optoelectronics, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $34.7M | $24.7M | $45.4M | $67.4M | $206M |
| Debt incl. finance leases | $54.8M | $57.1M | $23.2M | $26.7M | $34.0M |
| Debt / equity | 0.2x | 0.3x | 0.1x | 0.1x | 0.0x |
| Interest coverage | β10.1x | β9.3x | β4.4x | β10.4x | β15.6x |
| Current ratio | 1.8x | 1.3x | 1.8x | 1.8x | 2.6x |
| Quick ratio | 0.9x | 0.7x | 1.2x | 1.3x | 1.9x |
| Total assets | $454M | $408M | $389M | $547M | $1.2B |
| Total liabilities | $200M | $224M | $174M | $318M | $435M |
| Shareholders' equity | $255M | $185M | $215M | $229M | $734M |
| Net debt (β = net cash) | $20.1M | $32.5M | β$22.2M | β$40.7M | β$172M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 8 / 9 | 3 / 9 | 2 / 9 | 3 / 9 | 2 / 9 | 2 / 9 | 6 / 9 | 2 / 9 | 4 / 9 |
| Accruals ratio | β8.0% | β2.7% | β3.5% | β13.8% | β3.0% | β9.1% | β12.1% | β12.1% | β25.0% | 15.9% |
| Altman Z'' | 4.61 | 6.79 | 4.25 | 2.00 | 1.60 | 0.70 | β1.06 | β0.30 | β1.23 | 2.44 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $261M | $382M | $267M | $191M | $235M | $212M | $223M | $218M | $249M | $456M |
| Gross profit | $87.0M | $166M | $87.8M | $46.2M | $50.5M | $37.7M | $33.6M | $58.9M | $61.8M | $137M |
| Research and development | $31.8M | $35.4M | $49.9M | $43.4M | $43.4M | $41.2M | $36.2M | $36.0M | $55.0M | $85.5M |
| Operating income | $23.0M | $87.0M | β$10.8M | β$48.7M | β$48.8M | β$56.8M | β$59.0M | β$41.3M | β$70.9M | β$54.6M |
| Interest expense | $1.7M | $0.9M | $1.1M | $5.4M | $5.6M | $5.6M | $6.3M | $9.4M | $6.8M | $3.5M |
| Pretax income | $21.0M | $84.5M | β$9.8M | β$51.4M | β$51.2M | β$54.2M | β$66.4M | β$56.0M | β$187M | β$46.7M |
| Income tax | β$10.2M | $10.6M | β$7.6M | $14.7M | $7.2M | $0.0M | $0.0M | $0.0M | $0.0M | β$8.5M |
| Net income | $31.2M | $74.0M | β$2.1M | β$66.0M | β$58.5M | β$54.2M | β$66.4M | β$56.0M | β$187M | β$38.2M |
| Net income to common | $31.2M | $74.0M | β | β | β | β | β | β | β | β |
| Diluted EPS | $1.76 | $3.67 | β$0.11 | β$3.31 | β$2.67 | β$2.01 | β$2.38 | β$1.75 | β$4.50 | β$0.64 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B | 0.04B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $57.1M | $84.3M | $14.0M | β$1.8M | β$44.0M | β$11.6M | β$14.0M | β$7.9M | β$69.5M | β$174M |
| Capital expenditure | $49.4M | $67.0M | $71.9M | $28.8M | $15.8M | $8.0M | $3.2M | $9.1M | $43.4M | $179M |
| Free cash flow | $7.7M | $17.3M | β$57.8M | β$30.5M | β$59.8M | β$19.6M | β$17.2M | β$17.0M | β$113M | β$354M |
| Depreciation and amortization | $14.2M | $20.4M | $29.7M | $24.0M | $24.7M | $25.4M | $23.2M | $20.4M | $20.6M | $27.7M |
| Stock-based compensation | $3.8M | $7.8M | $11.1M | $11.8M | $13.0M | $12.1M | $9.6M | $11.9M | $14.8M | $11.7M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $50.3M | $83.0M | $55.6M | $60.0M | $43.4M | $34.7M | $24.7M | $45.4M | $67.4M | $206M |
| Total debt | $42.8M | $49.5M | $83.9M | $49.9M | $52.2M | $54.7M | $57.1M | $23.2M | $26.7M | $34.0M |
| Finance lease liabilities | β | β | β | $0.1M | $0.1M | $0.1M | $0.1M | $0.0M | β | β |
| Current assets | $158M | $230M | $194M | $193M | $209M | $194M | $183M | $173M | $301M | $676M |
| Current liabilities | $60.0M | $70.7M | $77.4M | $91.4M | $103M | $109M | $139M | $93.4M | $170M | $257M |
| Inventory | $51.8M | $75.8M | $93.3M | $85.0M | $110M | $92.5M | $79.7M | $63.9M | $88.1M | $183M |
| Property and equipment, net | $144M | $198M | $234M | $248M | $253M | $243M | $210M | $200M | $219M | $376M |
| Intangible assets | $4.0M | $4.0M | $4.0M | $4.1M | $4.0M | $3.8M | $3.7M | $3.6M | $3.7M | $3.6M |
| Total assets | $322M | $453M | $467M | $467M | $481M | $454M | $408M | $389M | $547M | $1.2B |
| Total liabilities | $94.9M | $120M | $138M | $193M | $203M | $200M | $224M | $174M | $318M | $435M |
| Preferred stock | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $227M | $333M | $329M | $274M | $278M | $255M | $185M | $215M | $229M | $734M |
| Margins | ||||||||||
| Gross margin | 33.4% | 43.5% | 32.8% | 24.2% | 21.5% | 17.8% | 15.1% | 27.1% | 24.8% | 30.0% |
| Operating margin | 8.8% | 22.7% | β4.0% | β25.5% | β20.8% | β26.8% | β26.5% | β19.0% | β28.4% | β12.0% |
| EBITDA margin | 14.3% | 28.1% | 7.1% | β13.0% | β10.3% | β14.8% | β16.1% | β9.6% | β20.2% | β5.9% |
| Net margin | 12.0% | 19.3% | β0.8% | β34.6% | β24.9% | β25.6% | β29.8% | β25.8% | β74.9% | β8.4% |
| FCF margin | 2.9% | 4.5% | β21.6% | β16.0% | β25.5% | β9.3% | β7.7% | β7.8% | β45.3% | β77.6% |
| Returns | ||||||||||
| Return on capital | 10.5% | 25.4% | β2.4% | β14.6% | β13.5% | β16.3% | β21.5% | β17.0% | β29.7% | β7.7% |
| Return on capital employed | 8.8% | 22.7% | β2.8% | β13.0% | β12.9% | β16.4% | β21.9% | β14.0% | β18.8% | β6.0% |
| Return on equity | 13.7% | 26.4% | β0.6% | β21.9% | β21.2% | β20.3% | β30.2% | β28.1% | β84.1% | β7.9% |
| Return on assets | 9.7% | 19.1% | β0.5% | β14.1% | β12.3% | β11.6% | β15.4% | β14.1% | β39.9% | β4.5% |
| Return on tangible equity | 14.0% | 22.5% | β0.7% | β24.5% | β21.3% | β21.6% | β36.7% | β26.5% | β82.8% | β5.2% |
| Growth | ||||||||||
| Revenue growth | β | 46.6% | β30.0% | β28.6% | 22.9% | β9.8% | 5.3% | β2.3% | 14.6% | 82.8% |
| Net income growth | β | 136.8% | β102.9% | β | β | β | β | β | β | β |
| EPS growth | β | 108.5% | β103.0% | β | β | β | β | β | β | β |
| FCF growth | β | 126.0% | β433.9% | β | β | β | β | β | β | β |
| Share count change | β | 13.7% | β2.4% | 1.7% | 9.4% | 23.1% | 3.5% | 14.7% | 30.0% | 44.9% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.2x | β0.3x | 1.5x | β | β | β | β | β | β | β |
| Debt / equity | 0.2x | 0.1x | 0.3x | 0.2x | 0.2x | 0.2x | 0.3x | 0.1x | 0.1x | 0.0x |
| Interest coverage | 13.4x | 101.3x | β9.7x | β9.0x | β8.7x | β10.1x | β9.3x | β4.4x | β10.4x | β15.6x |
| Current ratio | 2.6x | 3.2x | 2.5x | 2.1x | 2.0x | 1.8x | 1.3x | 1.8x | 1.8x | 2.6x |
| Quick ratio | 1.8x | 2.2x | 1.3x | 1.2x | 1.0x | 0.9x | 0.7x | 1.2x | 1.3x | 1.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 19.0% | 17.5% | 26.9% | 15.1% | 6.7% | 3.8% | 1.4% | 4.2% | 17.4% | 39.3% |
| Stock comp / revenue | 1.5% | 2.0% | 4.2% | 6.2% | 5.6% | 5.7% | 4.3% | 5.5% | 5.9% | 2.6% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 8.0 | 3.0 | 2.0 | 3.0 | 2.0 | 2.0 | 6.0 | 2.0 | 4.0 |
| Altman Z'' | 4.6 | 6.8 | 4.2 | 2.0 | 1.6 | 0.7 | β1.1 | β0.3 | β1.2 | 2.4 |
| Accruals ratio | β8.0% | β2.7% | β3.5% | β13.8% | β3.0% | β9.1% | β12.1% | β12.1% | β25.0% | 15.9% |
Source: SEC EDGAR XBRL filings (CIK 0001158114). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.